Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer

PURPOSE: Androgen receptor splice variant 7 (AR-V7) detection in circulating tumor cells (CTCs) is associated with a low probability of response and short progression-free (PFS) and overall survival (OS) in men with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide or...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:JCO Precis Oncol
Main Authors: Armstrong, Andrew J., Luo, Jun, Nanus, David M., Giannakakou, Paraskevi, Szmulewitz, Russell Z., Danila, Daniel C., Healy, Patrick, Anand, Monika, Berry, William R., Zhang, Tian, Harrison, Michael R., Lu, Changxue, Chen, Yan, Galletti, Giuseppe, Schonhoft, Joseph D., Scher, Howard I., Wenstrup, Richard, Tagawa, Scott T., Antonarakis, Emmanuel S., George, Daniel J., Halabi, Susan
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Clinical Oncology 2020
נושאים:
Original Reports
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7608579/
https://ncbi.nlm.nih.gov/pubmed/33154984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.20.00200
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים